Safety and Efficacy Study Using Rexin-G for Breast Cancer

NCT00505271 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Epeius Biotechnologies